Welltower Inc. is one of the largest healthcare-focused REITs in the world, positioned at the center of the "silver economy" with a portfolio of more than 2,500 seniors and wellness housing communities across the United States, United Kingdom, and Canada. Its earnings carry broad relevance because the company is a bellwether for the seniors housing sector, where favorable demographics, constrained new supply, and rising occupancy have driven unusually strong operating leverage. In its most recent quarter, Welltower delivered a 20.5% increase in seniors housing operating same-store NOI and raised its full-year guidance. This third quarter report will test whether that momentum, and the premium valuation investors have assigned to the stock, remain justified. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
For the third quarter of 2026, the consensus estimate for normalized FFO is $1.64 per diluted share, which would represent an increase of roughly 22% from the $1.34 reported in the prior-year period. Revenue is expected to come in near $3.6 billion, reflecting the company's aggressive acquisition activity and improving occupancy levels. These figures follow a second quarter in which Welltower reported normalized FFO of $1.60 per share, up 25% year over year, alongside a 15.5% increase in total same-store NOI.
Beyond the headline numbers, investors will watch the seniors housing operating segment closely, since it now contributes the majority of the company's NOI. Key metrics include average occupancy, revenue per occupied room, and same-store NOI growth. Analysts have also noted the potential for continued upside from Welltower's external growth, with the company having indicated more than $5 billion of additional seniors housing acquisitions in the second half of 2026.
Sentiment heading into the third quarter report remains constructive but demanding. Welltower has been one of the best-performing large-cap REITs, and its shares trade at a premium to sector peers, which raises the bar for the company to deliver another strong quarter. The stock has historically reacted to both the magnitude of same-store NOI growth and any changes to full-year guidance. KeyBanc recently raised its price target on Welltower to $275 from $240, citing stronger seniors housing operating fundamentals and continued external growth. However, risks heading into the print include any signs that occupancy gains are slowing, labor cost pressures in the operating portfolio, or a smaller-than-expected boost from newly closed acquisitions. From what I see, I’m watching this closely as the bar for outperformance stays high.
Following the report, investors should watch whether management reaffirms or raises its full-year 2026 normalized FFO guidance, which was most recently set at a range of $6.36 to $6.44 per share. Any revision would signal how management views occupancy, pricing power, and the integration of new assets through year-end.
Acquisition activity will remain a central theme. Welltower has been deploying capital at a rapid pace, and the timing and pricing of new deals will influence both near-term earnings and the balance sheet. Monitoring leverage levels, measured against adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA), will help investors assess the sustainability of that growth.
Finally, pay attention to operating-cost trends, including labor expenses in the seniors housing segment, and to any commentary on interest rates and financing costs, which directly affect a capital-intensive REIT. Together, these factors will shape the outlook for the company's dividend and its ability to keep compounding per-share growth.
In my view, staying ahead of earnings season often means combining traditional analysis with modern screening tools. I’ve found Tickeron’s AI-powered platforms useful for quickly filtering opportunities across sectors and identifying patterns that might not be obvious at first glance. One thing that stands out is how these resources can help refine a watchlist without replacing core fundamental work.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
WELL saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on November 19, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 42 instances where the indicator turned negative. In 22 of the 42 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 52%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 27 of 62 cases where WELL's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 44%.
The Momentum Indicator moved below the 0 level on November 19, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on WELL as a result. In 34 of 77 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 44%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where WELL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 48%.
WELL broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for WELL entered a downward trend on October 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
WELL moved above its 50-day moving average on October 30, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for WELL crossed bullishly above the 50-day moving average on October 23, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 7 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 54%.
Following a +1.06% 3-day Advance, the price is estimated to grow further. Considering data from situations where WELL advanced for three days, in 229 of 355 cases, the price rose further within the following month. The odds of a continued upward trend are 65%.
The Tickeron Profit vs. Risk Rating rating for this company is 2 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 58, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 32 (best 1 - 100 worst), indicating outstanding price growth. WELL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 73 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 86 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 98 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.804) is normal, around the industry mean (3.134). WELL has a moderately high P/E Ratio (110.365) as compared to the industry average of (30.791). WELL's Projected Growth (PEG Ratio) (3.660) is slightly higher than the industry average of (1.649). Dividend Yield (0.014) settles around the average of (0.050) among similar stocks. WELL's P/S Ratio (13.316) is slightly higher than the industry average of (6.013).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a real estate investment trust
Industry PublishingBooksMagazines